Related Experiment Video
Updated: Jan 5, 2026

05:27
Author Spotlight: RNA FISH for Locating lncRNA-SNHG6 in Osteosarcoma Cells
Published on: June 16, 2023
2.2K
Long non-coding RNA TUSC7 suppresses osteosarcoma by targeting miR-211
1Department of Orthopaedic, Qi Lu Hospital of Shandong University, No.107 Wenhua Xi Road, Jinan City 250012, Shandong Province, P.R. China.
Bioscience Reports
|October 26, 2019
Summary
Long non-coding RNA tumor suppressor candidate 7 (TUSC-7) inhibits osteosarcoma progression by suppressing miR-211. This study reveals a novel regulatory mechanism and potential therapeutic strategy for osteosarcoma.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Long non-coding RNAs (lncRNAs) are crucial regulators of cancer progression and metastasis.
- LncRNA tumor suppressor candidate 7 (TUSC-7) exhibits tumor suppressor activity in osteosarcoma.
- The regulatory mechanisms of TUSC-7 in osteosarcoma remain largely unelucidated.
Purpose of the Study:
- To investigate the regulatory mechanism of TUSC-7 in osteosarcoma.
- To explore the interaction between TUSC-7 and miR-211.
- To elucidate the role of the TUSC-7/miR-211 axis in osteosarcoma progression.
Main Methods:
- Bioinformatics analysis to predict interactions.
- RNA pull-down and luciferase reporter assays to validate interactions.
- Overexpression studies to assess functional effects on cell proliferation, migration, and apoptosis.
Main Results:
- TUSC-7 specifically binds to miR-211, with reciprocal inhibition observed.
- miR-211 is upregulated in osteosarcoma and inversely correlated with TUSC-7 expression.
- TUSC-7 overexpression inhibits osteosarcoma cell proliferation and migration while promoting apoptosis, largely mediated by miR-211.
Conclusions:
- TUSC-7 functions as a tumor suppressor in osteosarcoma.
- TUSC-7 is negatively regulated by miR-211, forming a crucial regulatory axis.
- The TUSC-7/miR-211 pathway presents a potential therapeutic target for osteosarcoma.
Related Concept Videos
MicroRNAs
3.7K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.7K
MicroRNAs
23.8K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.8K
lncRNA - Long Non-coding RNAs
9.7K
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.7K
lncRNA - Long Non-coding RNAs
3.4K
3.4K
Experimental RNAi
7.2K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
7.2K
Rous Sarcoma Virus (RSV) and Cancer
6.1K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
6.1K
